Torrey Pines Institute For Molecular Studies

Torrey Pines Institute For Molecular Studies

Torrey Pines Institute for Molecular Studies, also commonly referred to as TPIMS, is a non-profit biomedical research institute "dedicated to the discovery of causes, treatments and cures for a wide variety of diseases and afflictions including heart disease, cancer, AIDS, diabetes, multiple sclerosis, Alzheimer's, aging-relating conditions, and pain management. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Torrey Pines Institute For Molecular Studies, United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

53%


Total
Publications

2.1K


Total Open
Publications

1.1K


Total
Citations

135K


Open Access
Percentage

53%


Total
Publications

2.1K


Total Open
Publications

1.1K


Total
Citations

135K

Wikipedia

Website

download

Breakdown

12% 21% 20% 47%

Publisher Open

12%

Both

21%

Other Platform Open

20%

Closed

47%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

26%OA Journal

OA Journal 26%

184

Hybrid 34%

235

No Guarantees 40%

279

Other Platform Open

Domain 88%

756

Institution 14%

124

Public 10%

89

Other Internet 7%

63

Preprint 6%

49

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
752
Europe PMC
Domain
646
Semantic Scholar
Public
69
bioRxiv
Preprint
29
Figshare
Public
27
California Digital Library - eScholarship
Other Internet
19
DOI
Other Internet
18
CiteSeer X
Other Internet
16
University of California - eScholarship University of California
Institution
14
nova.edu OAI-PMH Repository
Institution
14
1 / 10

Data updated 13 May 2024

Share

Share

Share